Healthcare - Biotechnology - NASDAQ - US
$ 44.75
-6.07 %
$ 4.13 B
Market Cap
-7.05
P/E
INCOME STATEMENT
434 M
REVENUE
-569 M
OPERATING INCOME
-607 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Ultragenyx Pharmaceutical Inc.
| Revenue | 434 M |
| Cost Of Revenue | 45.2 M |
| Gross Profit | 389 M |
| Operating Expenses | 958 M |
| Operating Income | -569 M |
| Other Expenses | 37.4 M |
| Net Income | -607 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||
| Revenue | 434.2 | 363.3 | 351.4 | 271.0 | 103.7 | 51.5 | 2.6 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||||||
| Cost Of Revenue | 45.2 | 28.3 | 16.0 | 6.1 | 9.0 | 1.1 | 1 K | 183.2 | 1.4 | 0 | 0 | 0 | 0 |
| Gross Profit | 389.0 | 335.0 | 335.4 | 264.9 | 94.7 | 50.3 | 2.6 | (183.1) | (1.4) | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||||||
| Operating Expenses | 958.2 | 983.9 | 717.1 | 595.0 | 518.9 | 421.7 | 331.6 | 248.1 | 147.7 | 56.8 | 32.3 | 16.0 | 6.6 |
| Selling, General and Administrative Expenses | 309.8 | 278.1 | 220.0 | 182.9 | 161.5 | 127.7 | 99.9 | 64.9 | 33.0 | 10.8 | 4.5 | 3.3 | 1.8 |
| Research and Development Expenses | 648.4 | 705.8 | 497.2 | 412.1 | 357.4 | 294.0 | 231.6 | 183.2 | 114.7 | 46.0 | 27.8 | 12.6 | 4.7 |
| Operating Income | (569.2) | (648.9) | (381.7) | (330.1) | (424.2) | (371.4) | (328.9) | (248.0) | (147.7) | (56.8) | (32.3) | (16.0) | (6.6) |
| PRE-TAX INCOME | |||||||||||||
| Interest Income Expense | 66.0 | 43.0 | 29.4 | 33.3 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 |
| Total Other Income | (39.3) | (52.8) | (71.2) | 144.8 | 24.7 | 174.3 | 10.6 | 2.2 | 2.1 | (3.0) | (2.8) | (0.3) | (0.3) |
| Pre-Tax Income | (608.5) | (701.7) | (453.0) | (185.4) | (399.4) | (197.1) | (318.3) | (245.8) | (145.6) | (59.8) | (35.1) | (16.3) | (6.8) |
| NET INCOME | |||||||||||||
| Tax Provision | (1.8) | 5.7 | 1.0 | 1.2 | 3.3 | 0.5 | (16.2) | 35 K | (2.3) | (0.7) | (3.0) | (0.3) | 0.2 |
| Net Income | (606.6) | (707.4) | (454.0) | (186.6) | (402.7) | (197.6) | (302.1) | (245.9) | (145.6) | (59.8) | (35.1) | (16.3) | (6.8) |
| EPS | 8.25 | 10.1 | 6.7 | 3.07 | 7.12 | 3.97 | 7.12 | 6.21 | 3.96 | 2.08 | 1.21 | 0.71 | 0.3 |